Avoro Capital Advisors LLC - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 51 filers reported holding DESIGN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Avoro Capital Advisors LLC ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$22,050,000
+9.2%
3,500,0000.0%0.30%0.0%
Q1 2023$20,195,000
-13.4%
3,500,000
+54.0%
0.30%
-14.1%
Q4 2022$23,312,998
-37.3%
2,272,222
+2.3%
0.35%
-49.3%
Q3 2022$37,156,000
+19.4%
2,222,2220.0%0.69%
+11.5%
Q2 2022$31,111,000
-13.3%
2,222,2220.0%0.62%
-6.1%
Q1 2022$35,889,000
+2.5%
2,222,222
+35.8%
0.66%
+9.9%
Q4 2021$35,029,000
+62.4%
1,636,100
+11.4%
0.60%
+75.8%
Q3 2021$21,570,000
-18.3%
1,468,3180.0%0.34%
-26.1%
Q2 2021$26,410,000
-33.5%
1,468,3180.0%0.46%
-33.1%
Q1 2021$39,702,0001,468,3180.69%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,526,476$15,402,4837.89%
Logos Global Management LP 5,032,501$11,876,7021.58%
Prosight Management, LP 1,203,745$2,840,8380.90%
TANG CAPITAL MANAGEMENT LLC 1,350,000$3,186,0000.45%
Soleus Capital Management, L.P. 1,025,000$2,419,0000.22%
RTW INVESTMENTS, LP 2,512,986$5,930,6470.12%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 180,000$425,0000.09%
Corton Capital Inc. 27,134$64,0360.03%
OCCUDO QUANTITATIVE STRATEGIES LP 100,722$237,7040.03%
Rock Springs Capital Management LP 460,391$1,086,5230.03%
View complete list of DESIGN THERAPEUTICS INC shareholders